BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2014 8:55:00 PM | Browse: 977 | Download: 689
Publication Name World Journal of Meta-Analysis
Manuscript ID 3800
Country United States
Received
2013-05-24 10:01
Peer-Review Started
2013-05-24 15:16
To Make the First Decision
2013-08-21 18:45
Return for Revision
2013-08-27 14:46
Revised
2013-10-03 22:23
Second Decision
2013-10-19 14:48
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-10-20 08:32
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-12-03 11:28
Publish the Manuscript Online
2013-12-19 19:04
ISSN 2308-3840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Psychiatry
Manuscript Type Meta-Analysis
Article Title Meta-analysis of anti-ribosomal P antibodies in lupus psychosis
Manuscript Source Invited Manuscript
All Author List Kim Linz and Brian J Miller
Funding Agency and Grant Number
Funding Agency Grant Number
National Institute of Mental Health 1K23MH098014
Georgia Regents University
Medscape, Insight Consulting, and Decision Resources Group
Corresponding Author Brian J Miller, MD, PhD, MPH, Department of Psychiatry and Health Behavior, Georgia Regents University, 997 Saint Sebastian Way, Augusta, GA 30912, United States. brmiller@gru.edu
Key Words Systemic lupus erythematosus; Psychosis; Autoantibodies; Anti-ribosomal P antibodies; Meta-analysis
Core Tip In a meta-analysis of twenty-four studies, positive anti-ribosomal P (aRP) antibodies were found in 51% (91 of 179 total cases) of cases of lupus psychosis. There was an almost 3.5-fold increased odds of psychosis in aRP-positive patients (OR = 3.46, 95%CI: 1.97-6.09, P < 0.001). The population attributable risk percentage was 36% for aRP antibodies. aRP antibodies are common in lupus psychosis, although the potential mechanism(s) underlying this association remain unclear. Given the overlap between the clinical presentation and risk factors for lupus psychosis and schizophrenia, further investigation of aRP antibodies in schizophrenia is warranted.
Publish Date 2013-12-19 19:04
Citation Linz K, Miller BJ. Meta-analysis of anti-ribosomal P antibodies in lupus psychosis. World J Meta-Anal 2013; 1(3): 121-129
URL http://www.wjgnet.com/2308-3840/full/v1/i3/121.htm
DOI http://dx.doi.org/10.13105/wjma.v1.i3.121
Full Article (PDF) WJMA-1-121.pdf
Manuscript File 3800-Review.docx
Answering Reviewers 3800-Answering Reviewers.pdf
Copyright License Agreement 3800-Copyright Assignment.pdf
Peer-review Report 3800-Peer Review(s).pdf
Scientific Editor Work List 3800-Scientific editor work list.doc